Key facts
- Alto Pharmacy’s last known valuation is $800.0M.
- It has raised $760.0M.
- Notable investors include Gaingels.
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Alto Pharmacy
- ·The full record, as it builds
Funding rounds
No funding rounds for Alto Pharmacy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alto Pharmacy
Alto Pharmacy is a telehealth pharmacy that aims to make the prescription experience easier for people seeking a healthier life. The dedicated team of pharmacists, engineers, and care specialists at Alto tirelessly work towards raising the standards of pharmacy services. As a prescription management partner, Alto provides delivery, advice, discounts, and on-call support to patients. With a focus on the crucial role of pharmacists in healthcare journeys, Alto combines expert pharmacist care with purpose-built technology to offer a convenient and affordable medication experience.
- Founded
- 2015
- Employees
- 810
- Website
- alto.com
Alto Pharmacy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alto Pharmacy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alto Pharmacy in its N-PORT filings yet. We sweep new filings monthly.